Find talented Pfizer employees at the Pfizer Career Center.
6/17 6:30 pm
Connecticut's BIO 2012 BioPharma Reception, Anthony's Pier 4, 140 Northern Avenue, Boston, MA. more
6/18-6/21 2012 BIO International Convention, Boston Convention & Exhibition Center, Boston, MA more
7/12 8:30 am - 11:30 am
CBIA presents 'Tackling Intellectual Property Issues on an International Playing Field.' CBIA, 350 Church Street, Hartford more
7/24-7/26
SBIR and Global Trade Summit. Mohegan Sun, Uncasville, CT more
12/4 5:45 pm - 7:30 pm
CURE Holiday Party.'The best networking in town.' Save the date. Details to come.



Co-Chair
Peter R. Farina, Ph.D., chief executive officer, Developing World Cures, Inc.

Co-Chair
David W. Keiser, director, CureFAKtor LLC

President & CEO
Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE

Secretary
Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Treasurer
Michelle Bowman, partner, PricewaterhouseCoopers LLP


Executive Committee Members

Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Jame G. Baxter, Pharm.D., Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

Derek Chalmers , Ph.D., president & CEO, Cara Therapeutics, Inc.

Peter R. Farina, Ph.D., chief executive officer, Developing World Cures, Inc.

David W. Keiser, director, CureFAKtor LLC

Frank J. Marco, J.D., partner, Wiggin and Dana LLP

Harry H. Penner, Jr., president & CEO, New Haven Pharmaceuticals, Inc.

Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE

Kevin Rakin, president, Advanced BioHealing

David I. Scheer, president, Scheer and Company


Board of Directors

Daniel D. Adams, executive chairman, Protein Sciences Corporation

Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Philip E. Austin, president, University of Connecticut

James G. Baxter, Pharm.D., Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

Laurine M. Bow, vice president for research and director, transplant immunology, Hartford Hospital.

Michelle Bowman, partner, PricewaterhouseCoopers LLP

Derek Chalmers, Ph.D., president & CEO, Cara Therapeutics, Inc

Thomas Dubin, senior vice president and chief legal officer, Alexion Pharmaceuticals, Inc.

Peter R. Farina, Ph.D., chief executive officer, Developing World Cures, Inc.

Judith B. Greiman, president, Connecticut Conference of Independent Colleges

Joseph P. Hammang, Ph.D., senior director, worldwide science policy, Pfizer, Inc.

James W. Heins, senior director, public affairs, Purdue Pharma

Peter R. Hicks, vice president, emerging growth and technologies, Webster Bank

David W. Keiser, director, CureFAKtor LLC

Michael D. Kishbauch, president and CEO, Achillion Pharmaceuticals, Inc.

Hollis D. Kleinert, Ph.D., president, Kleinert Scientific/Commercial Consultations

Mark Leuchtenberger, president & CEO, Rib-X Pharmaceuticals, Inc.

David M. Mack, J.D., partner, Shipman & Goodwin LLP

Frank J. Marco, J.D., partner, Wiggin and Dana LLP

Anthony Marone, vice president, client & external relations, The United Illuminating Company

Juergen Martens , Ph.D., corporate vice president of technical operations and chief technical officer, MannKind Corporation

Christopher K. McLeod, president and CEO, 454 Life Sciences

Sandra S. Oliver, vice president of public policy & state government affairs, Bayer HealthCare

Harry H. Penner, Jr., president & CEO, New Haven Pharmaceuticals, Inc.

Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE

Kevin Rakin, president, Advanced BioHealing

Jonathan M. Rothberg, Ph.D., CEO and chairman, Ion Torrent

Seth A. Rudnick, M.D., general partner, Canaan Partners

David I. Scheer, president, Scheer and Company

Michael Schmertzler, CEO & president, Kolltan Pharmaceuticals, Inc.

Designed by BlausenLisi
Copyright © 2006 Connecticut United for Research Excellence, Inc.